These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3764377)

  • 1. [Cyclosporin A in acute Crohn disease: initial findings].
    Marbet UA; Gyr K; Stalder GA
    Schweiz Med Wochenschr; 1986 Jul; 116(29):962-3. PubMed ID: 3764377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crohn disease: initial experiences with cyclosporin A in an adolescent girl].
    Dannecker G; Malchow H; Niessen KH; Ranke MB
    Dtsch Med Wochenschr; 1985 Mar; 110(9):339-43. PubMed ID: 2857635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
    Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steroid resistance of Crohn's disease.
    Mingrone G; DeGaetano A; Pugeat M; Capristo E; Greco AV; Gasbarrini G
    J Investig Med; 1999 Jul; 47(6):319-25. PubMed ID: 10431487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute relapsing pancreatitis, revealing Crohn disease, and regressing under corticotherapy].
    Malka D; Lévy P; Chemtob A; Bernades P
    Gastroenterol Clin Biol; 1994; 18(10):892-4. PubMed ID: 7875399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor/cachectin in Crohn's disease. Relation of serum concentration to disease activity.
    Sategna-Guidetti C; Pulitanò R; Fenoglio L; Bologna E; Manes M; Camussi G
    Recenti Prog Med; 1993 Feb; 84(2):93-9. PubMed ID: 8465094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastroduodenal, ileocolic and perianal Crohn's disease].
    Martins T; Correia F; Gonçalves P; Proença R; de Sousa S; Dias R
    Acta Med Port; 1996; 9(7-9):279-82. PubMed ID: 9005711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Crohn's disease in relapse with cyclosporin A.
    Parrott NR; Taylor RM; Venables CW; Record CO
    Br J Surg; 1988 Dec; 75(12):1185-8. PubMed ID: 3069176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prednisolone as prophylaxis for endoscopic ileal recurrence after resection in patients with Crohn's disease.
    Smedh K; Olaison G; Teder K; Sjödahl R
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):485-6. PubMed ID: 7614114
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose naltrexone therapy improves active Crohn's disease.
    Smith JP; Stock H; Bingaman S; Mauger D; Rogosnitzky M; Zagon IS
    Am J Gastroenterol; 2007 Apr; 102(4):820-8. PubMed ID: 17222320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
    Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
    Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ
    Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
    Frieri G; Pimpo MT; Palumbo G; Tonelli F; Annese V; Sturniolo GC; Andreoli A; Comberlato M; Corrao G; Caprilli R
    Am J Gastroenterol; 2000 Jun; 95(6):1486-90. PubMed ID: 10894584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
    Korzenik JR; Dieckgraefe BK
    Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A successful switch from prednisone to budesonide for neuropsychiatric adverse effects in a patient with ileal Crohn's disease.
    Nahon S; Pisanté L; Delas N
    Am J Gastroenterol; 2001 Jun; 96(6):1953-4. PubMed ID: 11419871
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiated therapy in Crohn's disease].
    Riemann JF
    Fortschr Med; 1981 Feb; 99(5):129-33. PubMed ID: 6115804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.